SANTA CLARA, Calif., — Agilent Technologies Inc. (NYSE: A) today announced that it was awarded a significant patent for comparative genomic hybridization methods. CGH methods help researchers study genetics and cancer in both basic and clinical research. The U.S. patent (No. 8,232,055) has claims for measuring copy number changes in genomic DNA, covering both one-color […]
Huntsville, AL – MI has parlayed their extensive expertise in all aspects of gene expression science to meet the demand for custom laboratory services for both large and small gene expression projects. Available across a range of diagnostic, drug development and life sciences applications, the MI Services Lab offers the widest availability of microarrays for […]
Gaithersburg, MD — Meso Scale Diagnostics, LLC. (MSD) is pleased to announce that its Quality Management System has been certified as meeting the standards of ISO 9001:2008 and ISO 13485:2003. “The achievement of these certifications is indicative of MSD’s commitment to meet the ongoing quality requirements of our customers,” said Jacob Wohlstadter, President and Chief […]
Agilent Technologies Inc. (NYSE: A) today announced a favorable legal ruling from the European Patent Office regarding Agilent’s opposition to patent EP 0853679, assigned to Affymetrix. On Oct. 21, 2003, Agilent joined Combimatrix and Clonediag in opposing the patent, titled “Expression Monitoring by Hybridization to High Density Oligonucleotide Arrays.” Agilent opposed the breadth of the […]
HIGHLIGHTS: Q2 2012 Results (all percentages are to comparable periods in 2011) • Q2 2012 reported sales increased 4% to $664 million. Q2 2012 overall sales grew organically by 3% with Research and Sigma-Aldrich Fine Chemicals (“SAFC”) organic sales growth of 1% and 8%, respectively. Acquisitions contributed 6% to sales growth. Changes in foreign currency […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the second quarter of 2012. Second quarter 2012 results: • Revenue of $281 million, a 2% decrease compared to $287 million in the second quarter of 2011. • GAAP net income for the quarter of $23 million, or $0.18 per diluted share, compared […]
SKOKIE, Ill. – July 16, 2012 – NanoProfessor®, a division of NanoInk®, Inc. focused on nanotechnology education, announced that the newly launched Nanotechnology Employment, Education, and Economic Development Initiative (NE3I) has chosen the NanoProfessor Nanoscience Education Program to serve as the cornerstone of its educational activities, with the goal of making nanotechnology education accessible for […]
Long Beach, California -– This Sunday, CLC bio and BioFormatix – a medical diagnostics software developer – will officially release their Bootstrapped Receiver Operating Characteristic (bROC) plug-in for CLC bio’s desktop software packages, CLC Main Workbench and CLC Genomics Workbench. The plug-in and the process behind developing it will officially be presented during CLC bio’s […]
When the human genome project was completed in 2003, some expected it to herald a new age of personalized genomic medicine, but the resulting single “reference” sequence has significant shortcomings for these applications and does not account for the actual variability in the human population, as reported in a study published July 11 in the […]
NORCROSS, GA — RayBiotech, Inc. today announced the formal launch of a peptoid drug candidate & diagnostic ligand discovery service program. Peptoids, a chemically stable class of peptide mimetics, have been recently exploited as ligands to virtually any protein target including antibodies, cellular signaling molecules, or receptors. Aimed at the identification of novel ligands for […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
